468 related articles for article (PubMed ID: 15294958)
21. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
22. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
23. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity.
Tang A; Judge TA; Turka LA
Eur J Immunol; 1997 Dec; 27(12):3143-50. PubMed ID: 9464799
[TBL] [Abstract][Full Text] [Related]
24. MHC class II-KO mice are resistant to the immunosuppressive effects of UV light.
Krasteva M; Aubin F; Laventurier S; Kehren J; Assossou O; Kanitakis J; Kaiserlian D; Nicolas JF
Eur J Dermatol; 2002; 12(1):10-9. PubMed ID: 11809589
[TBL] [Abstract][Full Text] [Related]
25. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs.
Taraban VY; Rowley TF; Al-Shamkhani A
J Immunol; 2004 Dec; 173(11):6542-6. PubMed ID: 15557144
[TBL] [Abstract][Full Text] [Related]
26. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
27. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
Blachère NE; Morris HK; Braun D; Saklani H; Di Santo JP; Darnell RB; Albert ML
J Immunol; 2006 Jun; 176(12):7288-300. PubMed ID: 16751372
[TBL] [Abstract][Full Text] [Related]
28. Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells.
Kish DD; Volokh N; Baldwin WM; Fairchild RL
J Immunol; 2011 Feb; 186(4):2117-26. PubMed ID: 21239709
[TBL] [Abstract][Full Text] [Related]
29. CD4+CD25+ regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses.
Gorbachev AV; Fairchild RL
Eur J Immunol; 2010 Jul; 40(7):2006-15. PubMed ID: 20405474
[TBL] [Abstract][Full Text] [Related]
30. Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.
Jackaman C; Nelson DJ
Cancer Immunol Immunother; 2012 Apr; 61(4):549-60. PubMed ID: 22002241
[TBL] [Abstract][Full Text] [Related]
31. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
Clatza A; Bonifaz LC; Vignali DA; Moreno J
J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
[TBL] [Abstract][Full Text] [Related]
32. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
33. B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.
Wijesuriya R; Maruo S; Zou JP; Ogawa M; Umehara K; Yamashita M; Ono S; Fujiwara H; Hamaoka T
Int Immunol; 1998 Aug; 10(8):1057-65. PubMed ID: 9723691
[TBL] [Abstract][Full Text] [Related]
34. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells.
Koschella M; Voehringer D; Pircher H
J Immunol; 2004 Apr; 172(8):4804-11. PubMed ID: 15067057
[TBL] [Abstract][Full Text] [Related]
35. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes.
Rolph MS; Kaufmann SH
J Immunol; 2001 Apr; 166(8):5115-21. PubMed ID: 11290793
[TBL] [Abstract][Full Text] [Related]
36. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
[TBL] [Abstract][Full Text] [Related]
37. Differential requirements for Th1 and Th17 responses to a systemic self-antigen.
Katzman SD; Gallo E; Hoyer KK; Abbas AK
J Immunol; 2011 Apr; 186(8):4668-73. PubMed ID: 21402892
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
39. CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40.
Gregerson DS; Yang J
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3083-93. PubMed ID: 12824255
[TBL] [Abstract][Full Text] [Related]
40. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]